Vani Pachalla
Family Medicine · Saint Louis, MONPI 1063418382
Payments from drug & device makers
Across 96 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$370
- AbbVie$150
- Novo Nordisk$148
- Lilly USA, LLC$132
- Amgen$125
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$110
- plus $621 from 18 others
What the payments were for
- Food & beverage$1,57195%
- Other$845%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 20 | $370 |
| AbbVie | 9 | $150 |
| Novo Nordisk | 9 | $148 |
| Lilly USA, LLC | 9 | $132 |
| Amgen | 8 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $110 |
| Baxter Healthcare | 1 | $84 |
| Pfizer | 5 | $67 |
| Merck | 5 | $66 |
| Exact Sciences | 2 | $50 |
| Boehringer Ingelheim | 3 | $43 |
| Sanofi Pasteur Inc. | 1 | $38 |
| Indivior Inc. | 2 | $38 |
| Hologic Sales And Service, LLC | 2 | $37 |
| GSK | 3 | $37 |
| Verity Pharmaceuticals Inc. | 1 | $35 |
| Medtronic | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Radius Health, Inc. | 1 | $14 |
| Dynavax Technologies Corporation | 1 | $13 |
| Global Blood Therapeutics, Inc. | 1 | $12 |
| Redhill Biopharma Inc. | 1 | $11 |
How this compares
$1,656 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 119 | $127,747 |
| JardianceEmpagliflozin | 113 | $95,884 |
| TrulicityDulaglutide | 60 | $79,138 |
| FarxigaDapagliflozin Propanediol | 78 | $69,817 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 105 | $67,508 |
| EliquisApixaban | 80 | $51,913 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 40 | $29,878 |
| JanuviaSitagliptin Phosphate | 19 | $21,688 |
| JanumetSitagliptin Phos/Metformin Hcl | 27 | $21,615 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 28 | $17,289 |
| SymbicortBudesonide/Formoterol Fumarate | 53 | $13,536 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 15 | $13,061 |
| Spiriva RespimatTiotropium Bromide | 21 | $12,095 |
| Advair HfaFluticasone Propion/Salmeterol | 33 | $11,853 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 88 | $9,993 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $148 | $127,747119 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat | $43 | $125,268162 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Arexvy | $37 | $100,321160 claims |
| Lilly USA, LLCTrulicity | $132 | $79,13860 claims |
| MerckJanuvia, Janumet, Janumet Xr | $66 | $56,36461 claims |
| PfizerEliquis | $67 | $51,91380 claims |
| Sanofi-aventis U.S. LLCLantus | $19 | $2,60918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Saint Louis
- Rupal TrivediSaint Louis$10.6M
- Emily DoucetteSaint Louis$155K
- Michael DonovanSaint Louis$78K
- Jarad SchwartzSaint Louis$36K
- Christina RobinsSaint Louis$27K
- Michael SpeziaSaint Louis$26K
- Amanda BooneSaint Louis$17K
- David GlickSaint Louis$17K
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.